1. Home
  2. CSBR vs CCG Comparison

CSBR vs CCG Comparison

Compare CSBR & CCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSBR
  • CCG
  • Stock Information
  • Founded
  • CSBR 1985
  • CCG 2014
  • Country
  • CSBR United States
  • CCG China
  • Employees
  • CSBR N/A
  • CCG N/A
  • Industry
  • CSBR Biotechnology: Biological Products (No Diagnostic Substances)
  • CCG
  • Sector
  • CSBR Health Care
  • CCG
  • Exchange
  • CSBR Nasdaq
  • CCG Nasdaq
  • Market Cap
  • CSBR 90.0M
  • CCG 84.5M
  • IPO Year
  • CSBR 1986
  • CCG N/A
  • Fundamental
  • Price
  • CSBR $6.53
  • CCG $0.93
  • Analyst Decision
  • CSBR Strong Buy
  • CCG Buy
  • Analyst Count
  • CSBR 1
  • CCG 1
  • Target Price
  • CSBR $12.00
  • CCG $350.00
  • AVG Volume (30 Days)
  • CSBR 10.6K
  • CCG 89.9K
  • Earning Date
  • CSBR 12-12-2025
  • CCG 11-26-2025
  • Dividend Yield
  • CSBR N/A
  • CCG N/A
  • EPS Growth
  • CSBR N/A
  • CCG N/A
  • EPS
  • CSBR 0.21
  • CCG N/A
  • Revenue
  • CSBR $56,878,000.00
  • CCG $444,290,042.00
  • Revenue This Year
  • CSBR $7.31
  • CCG N/A
  • Revenue Next Year
  • CSBR $12.01
  • CCG $15.80
  • P/E Ratio
  • CSBR $30.46
  • CCG N/A
  • Revenue Growth
  • CSBR 10.11
  • CCG N/A
  • 52 Week Low
  • CSBR $4.07
  • CCG $0.71
  • 52 Week High
  • CSBR $11.99
  • CCG $1.54
  • Technical
  • Relative Strength Index (RSI)
  • CSBR 39.54
  • CCG 44.45
  • Support Level
  • CSBR $6.67
  • CCG $0.93
  • Resistance Level
  • CSBR $6.85
  • CCG $1.02
  • Average True Range (ATR)
  • CSBR 0.17
  • CCG 0.05
  • MACD
  • CSBR -0.05
  • CCG 0.01
  • Stochastic Oscillator
  • CSBR 1.79
  • CCG 38.98

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

About CCG Cheche Group Inc.

Cheche Group Inc is engaged in the operation of providing insurance transaction services, Software-as-a-Service (SaaS) services and other services in China.. It is China's independent technology-empowered platform for auto insurance transaction services by digital auto insurance transaction premiums and insurance technology companies. The company has reshaped the traditional auto insurance distribution and services value chain to create a digital platform by improving operational efficiencies, reducing transaction costs, and expanding distribution channels. Its business scope ranges from digital insurance transactions, SaaS platforms for insurance intermediaries, AI-driven insurance pricing and underwriting services, auto insurance services for new energy vehicle (NEV) manufacturers, etc.

Share on Social Networks: